
Sign up to save your podcasts
Or


Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
By The Lancet NeurologyJeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.

43,528 Listeners

298 Listeners

500 Listeners

50 Listeners

111,948 Listeners

93 Listeners

517 Listeners

188 Listeners

58 Listeners

84 Listeners

0 Listeners